Wake Forest Baptist Health receives $1.6 million grant to test iPad colon cancer screening app

NewsGuard 100/100 Score

Doctors know that screening for colorectal cancer reduces mortality. However, more than one-third of age-eligible Americans go unscreened every year even though colon cancer remains the second leading cause of cancer death in the United States.

In an effort to increase colorectal screenings, doctors at Wake Forest Baptist Health developed a specially designed iPad application that allows patients to order a colon cancer screening test while waiting at the doctor's office before a routine primary care visit.

Called mobile Patient Technology for Health-CRC (mPATH-CRC), the iPad app informs patients of their need for screening, helps them make a screening decision, lets them "self-order" a screening test and sends automated electronic messages to help them complete their chosen test.

Findings from a previous randomized trial of 450 patients published in the April 2018 edition of the journal Annals of Internal Medicine showed that use of the mPATH-CRC app doubled the proportion of patients who completed their colorectal screening.

Now thanks to a $1.6 million grant from the National Cancer Institute, mPATH-CRC will be tested in 28 primary care clinics in North Carolina and Kentucky.

While hundreds of mobile health apps have been developed in recent years, the best strategies for incorporating apps in routine primary care remain unknown.

Patients often have down time while they are waiting for their doctor. Our mPATH-CRC app makes good use of that currently wasted time by empowering patients with the tools and information they need to get the colorectal cancer screening test that is right for them."

Study's principal investigator, David Miller, M.D., professor of internal medicine at Wake Forest Baptist Health

This five-year project is designed to determine the optimal way to implement mPATH-CRC and other technology-based programs in community-based primary care practices, increasing the use of life-saving screening tests and improving the delivery of medical care.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New AI tool 'TORCH' successfully identifies cancer origins in unknown primary cases